Citi Pharma Limited (PSX:CPHL)

Citi Pharma Revenue

Citi Pharma had revenue of 3.34B PKR in the quarter ending March 31, 2025, a decrease of -6.12%. This brings the company's revenue in the last twelve months to 12.97B, down -0.75% year-over-year. In the fiscal year ending June 30, 2024, Citi Pharma had annual revenue of 12.41B with 0.10% growth.

• Revenue (ttm): 12.97B
• Revenue Growth: -0.75%
• P/S Ratio: 1.55
• Revenue / Employee: 25.00M
• Employees: 519
• Market Cap: 20.10B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	12.41B	12.26M	0.10%
Jun 30, 2023	12.40B	2.62B	26.76%
Jun 30, 2022	9.78B	3.98B	68.75%
Jun 30, 2021	5.80B	2.27B	64.29%
Jun 30, 2020	3.53B	920.60M	35.31%